These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12947394

  • 1. RAF antisense oligonucleotide as a tumor radiosensitizer.
    Kasid U, Dritschilo A.
    Oncogene; 2003 Sep 01; 22(37):5876-84. PubMed ID: 12947394
    [Abstract] [Full Text] [Related]

  • 2. Gene expression profile by inhibiting Raf-1 protein kinase in breast cancer cells.
    Mewani RR, Tian S, Li B, Danner MT, Carr TD, Lee S, Rahman A, Kasid UN, Jung M, Dritschilo A, Gokhale PC.
    Int J Mol Med; 2006 Mar 01; 17(3):457-63. PubMed ID: 16465392
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
    Soldatenkov VA, Dritschilo A, Wang FH, Olah Z, Anderson WB, Kasid U.
    Cancer J Sci Am; 1997 Mar 01; 3(1):13-20. PubMed ID: 9072302
    [Abstract] [Full Text] [Related]

  • 4. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
    Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC.
    Int J Oncol; 2004 May 01; 24(5):1181-8. PubMed ID: 15067340
    [Abstract] [Full Text] [Related]

  • 5. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C, Pei J, Kumar D, Sakabe I, Boudreau HE, Gokhale PC, Kasid UN.
    Methods Mol Biol; 2007 May 01; 361():163-85. PubMed ID: 17172711
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome.
    Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A, Kasid UN.
    Clin Cancer Res; 2002 Nov 01; 8(11):3611-21. PubMed ID: 12429653
    [Abstract] [Full Text] [Related]

  • 7. Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.
    Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang C, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN.
    Clin Cancer Res; 2006 Feb 15; 12(4):1251-9. PubMed ID: 16489081
    [Abstract] [Full Text] [Related]

  • 8. Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells.
    McPhillips F, Mullen P, MacLeod KG, Sewell JM, Monia BP, Cameron DA, Smyth JF, Langdon SP.
    Carcinogenesis; 2006 Apr 15; 27(4):729-39. PubMed ID: 16332724
    [Abstract] [Full Text] [Related]

  • 9. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y, Behar-Cohen F.
    Mol Vis; 2005 Mar 04; 11():184-91. PubMed ID: 15761390
    [Abstract] [Full Text] [Related]

  • 10. Raf: a strategic target for therapeutic development against cancer.
    Beeram M, Patnaik A, Rowinsky EK.
    J Clin Oncol; 2005 Sep 20; 23(27):6771-90. PubMed ID: 16170185
    [Abstract] [Full Text] [Related]

  • 11. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 20; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 12. Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer.
    Gokhale PC, Soldatenkov V, Wang FH, Rahman A, Dritschilo A, Kasid U.
    Gene Ther; 1997 Dec 20; 4(12):1289-99. PubMed ID: 9472552
    [Abstract] [Full Text] [Related]

  • 13. Antisense oligonucleotide therapy in urology.
    Kausch I, Böhle A.
    J Urol; 2002 Jul 20; 168(1):239-47. PubMed ID: 12050550
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.
    Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P.
    Cancer Res; 2002 Oct 01; 62(19):5393-8. PubMed ID: 12359742
    [Abstract] [Full Text] [Related]

  • 15. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA, Wilhelm S, Carter C, Kelley SL.
    Semin Oncol; 2006 Aug 01; 33(4):392-406. PubMed ID: 16890795
    [Abstract] [Full Text] [Related]

  • 16. First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.
    Monia BP.
    Anticancer Drug Des; 1997 Jul 01; 12(5):327-39. PubMed ID: 9236850
    [No Abstract] [Full Text] [Related]

  • 17. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells.
    Pirollo KF, Hao Z, Rait A, Ho CW, Chang EH.
    Biochem Biophys Res Commun; 1997 Jan 03; 230(1):196-201. PubMed ID: 9020045
    [Abstract] [Full Text] [Related]

  • 18. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M.
    J Natl Cancer Inst; 2004 Aug 04; 96(15):1171-80. PubMed ID: 15292389
    [Abstract] [Full Text] [Related]

  • 19. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.